Pediatric orbital masses from a tertiary pediatric oncology referral center: clinical characteristics and survival outcomes from a 20-year single-center experience

Pediatric orbital masses are uncommon and most reports originate from ophthalmology services, where benign lesions predominate; oncology-referral populations may differ and remain underreported. We reviewed children evaluated for proptosis and orbital mass at a tertiary pediatric oncology unit (2000–2020). Demographic features, diagnostic spectrum, tumor origin, age distribution, diagnostic approach, and survival outcomes were analyzed. Overall survival (OS) was estimated by Kaplan–Meier analysis and compared by log-rank testing. Prespecified exploratory comparisons included age (< 5 vs. ≥ 5 years), diagnostic approach, and metastatic neuroblastoma versus other malignant orbital tumors. A univariable Cox model explored the association between metastatic neuroblastoma and OS. Sixty patients were included (65% male), with median age of 4.74 years (IQR, 2.16–8.84 years). Malignant tumors comprised 88% (n = 53); benign lesions were 12% (n = 7) and mainly vascular. The most frequent diagnoses were metastatic neuroblastoma and optic pathway glioma (each 21.7%), followed by non-Hodgkin lymphoma and rhabdomyosarcoma (each 13.3%). Histopathology confirmed 85% (n = 51), whereas 15% (n = 9) were diagnosed radiologically, predominantly optic pathway gliomas. Diagnosis differed by age (< 5 vs. ≥ 5 years; p = 0.009), with metastatic neuroblastoma concentrated in children younger than 5 years (92.3%). Nine deaths occurred, all in malignant tumors. Metastatic neuroblastoma was associated with inferior overall survival and higher mortality risk than other orbital tumors. Pediatric orbital masses referred to oncology centers represent a high-risk population with a high malignancy rate. Rapidly progressive proptosis, particularly in children < 5 years, should prompt urgent evaluation for metastatic neuroblastoma. • This 20-year single-center study reflects a tertiary pediatric oncology referral population. • Malignancy predominated (88%), indicating a markedly different case mix from ophthalmology-based series. • Metastatic neuroblastoma and optic pathway glioma were the most frequent diagnoses. • Metastatic neuroblastoma clustered in children younger than 5 years and was associated with inferior overall survival.

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2026-03-28
DOI
https://doi.org/10.1186/s12887-026-06787-6
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pediatric orbital masses from a tertiary pediatric oncology referral center: clinical characteristics and survival outcomes from a 20-year single-center experience

Mehtap Ertekin, Gökalp Rüstem Aksoy, Aytul Temuroglu
BMC Pediatrics
Ocular Oncology and Treatments
article

Pediatric orbital masses from a tertiary pediatric oncology referral center: clinical characteristics and survival outcomes from a 20-year single-center experience

Mehtap Ertekin, Gökalp Rüstem Aksoy, Aytul Temuroglu
article en

Abstract

Pediatric orbital masses are uncommon and most reports originate from ophthalmology services, where benign lesions predominate; oncology-referral populations may differ and remain underreported. We reviewed children evaluated for proptosis and orbital mass at a tertiary pediatric oncology unit (2000–2020). Demographic features, diagnostic spectrum, tumor origin, age distribution, diagnostic approach, and survival outcomes were analyzed. Overall survival (OS) was estimated by Kaplan–Meier analysis and compared by log-rank testing. Prespecified exploratory comparisons included age (< 5 vs. ≥ 5 years), diagnostic approach, and metastatic neuroblastoma versus other malignant orbital tumors. A univariable Cox model explored the association between metastatic neuroblastoma and OS. Sixty patients were included (65% male), with median age of 4.74 years (IQR, 2.16–8.84 years). Malignant tumors comprised 88% (n = 53); benign lesions were 12% (n = 7) and mainly vascular. The most frequent diagnoses were metastatic neuroblastoma and optic pathway glioma (each 21.7%), followed by non-Hodgkin lymphoma and rhabdomyosarcoma (each 13.3%). Histopathology confirmed 85% (n = 51), whereas 15% (n = 9) were diagnosed radiologically, predominantly optic pathway gliomas. Diagnosis differed by age (< 5 vs. ≥ 5 years; p = 0.009), with metastatic neuroblastoma concentrated in children younger than 5 years (92.3%). Nine deaths occurred, all in malignant tumors. Metastatic neuroblastoma was associated with inferior overall survival and higher mortality risk than other orbital tumors. Pediatric orbital masses referred to oncology centers represent a high-risk population with a high malignancy rate. Rapidly progressive proptosis, particularly in children < 5 years, should prompt urgent evaluation for metastatic neuroblastoma. • This 20-year single-center study reflects a tertiary pediatric oncology referral population. • Malignancy predominated (88%), indicating a markedly different case mix from ophthalmology-based series. • Metastatic neuroblastoma and optic pathway glioma were the most frequent diagnoses. • Metastatic neuroblastoma clustered in children younger than 5 years and was associated with inferior overall survival.

BMC Pediatrics
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Izmir University (TR)
Good health and well-being
Openalex Percentile: Top 4%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.